Helen of Troy (HELE) Set to Release Quarterly Earnings on Thursday

Key Points

• Helen of Troy is scheduled to report Q2 fiscal 2027 results before the market opens on October 8. Analysts expect $0.505 in EPS and $443.2 million in revenue, while the company’s full-year EPS guidance is $3.25–$3.75.
• The company’s previous quarter exceeded expectations, reporting $0.17 EPS versus a $0.02 consensus estimate and $402.1 million in revenue, up 8.2% year over year.
• Analyst sentiment remains mixed: Helen of Troy has an average “Hold” rating and a $26.50 price target, while shares recently traded at $27.41, down 2.6%.

Helen of Troy (NASDAQ:HELE - Get Free Report) is expected to release its Q2 2027 results before the market opens on Thursday, October 8th. Analysts expect Helen of Troy to post earnings of $0.5050 per share and revenue of $443.2080 million for the quarter. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. Interested persons can find conference call details on the company's upcoming Q2 2027 earning summary page for the latest details on the call scheduled for Thursday, October 8, 2026 at 9:00 AM ET.

Helen of Troy (NASDAQ:HELE - Get Free Report) last issued its quarterly earnings results on Wednesday, July 8th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.15. Helen of Troy had a negative net margin of 22.70% and a positive return on equity of 6.46%. The business had revenue of $402.12 million for the quarter, compared to analysts' expectations of $374.55 million. During the same quarter in the prior year, the company earned $0.41 earnings per share. The business's quarterly revenue was up 8.2% on a year-over-year basis. On average, analysts expect Helen of Troy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Helen of Troy Trading Down 2.6%

NASDAQ HELE opened at $27.41 on Thursday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.81 and a current ratio of 1.78. The firm has a market cap of $638.38 million, a price-to-earnings ratio of -1.52 and a beta of 1.31. The firm has a 50 day simple moving average of $28.45 and a 200-day simple moving average of $24.98. Helen of Troy has a one year low of $13.85 and a one year high of $30.68.

Wall Street Analyst Weigh In

HELE has been the subject of several recent research reports. UBS Group raised their price target on shares of Helen of Troy from $25.00 to $28.00 and gave the company a "neutral" rating in a research report on Thursday, July 9th. Canaccord Genuity Group upped their price objective on Helen of Troy from $23.00 to $25.00 and gave the stock a "hold" rating in a research report on Thursday, July 9th. Wall Street Zen upgraded Helen of Troy from a "hold" rating to a "strong-buy" rating in a research note on Sunday, July 12th. Zacks Research lowered Helen of Troy from a "strong-buy" rating to a "hold" rating in a report on Monday, July 6th. Finally, Weiss Ratings lowered Helen of Troy from a "sell (d)" rating to a "sell (d-)" rating in a report on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Helen of Troy presently has an average rating of "Hold" and an average target price of $26.50.

Helen of Troy Company Profile

Helen of Troy Limited NASDAQ: HELE is a consumer products company that develops, manufactures, and markets branded products in the beauty, wellness, household, and outdoor categories. Its portfolio includes personal-care and beauty products, health and wellness devices, kitchen and household products, and hydration and outdoor recreation gear.

The company's well-known brands include OXO, Hydro Flask, Osprey, Drybar, Vicks, Braun, Hot Tools, Revlon, and Honeywell-branded products sold under license, among others.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.